Oceanaa Biotek Industries Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 13.57 Cr
as on 07-07-2024
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Revenue -29.23%
(FY 2020)
- Profit 110.48%
(FY 2020)
- Ebitda 126.22%
(FY 2020)
- Net Worth 8.33%
(FY 2020)
- Total Assets 4.67%
(FY 2020)
About Oceanaa Biotek Industries
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 538019.
The Corporate was formerly known as Oceanic Shelters Limited. The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 13.57 Cr, as per Ministry of Corporate Affairs (MCA) records.
Thomas Anbarasithenmozhi, Irudayaraj Raj, and Jesuraj serve as directors at the Company.
- CIN/LLPIN
L15549TN2005PLC057919
- Company No.
057919
- Stock Symbol
BSE : 538019
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2005
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Listed
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Oceanaa Biotek Industries?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thomas Anbarasithenmozhi  | Managing Director | 30-Jun-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Irudayaraj Raj | Director | 01-May-2013 | Current |
| Jesuraj | Director | 01-May-2013 | Current |
Financial Performance and Corporate Structure Insights of Oceanaa Biotek Industries.
Oceanaa Biotek Industries Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 29.23% decrease. The company also saw a substantial improvement in profitability, with a 110.48% increase in profit. The company's net worth moved up by a moderate rise of 8.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oceanaa Biotek Industries?
In 2020, Oceanaa Biotek Industries had a promoter holding of 39.09% and a public holding of 60.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oceanaa Biotek Industries?
Oceanaa Biotek Industries has a workforce of 4 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oceanaa Biotek Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oceanaa Biotek Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
